maxgraft® cortico

BONE AUGMENTATION WITH THE SHELL TECHNIQUE

SHORTER TREATMENT TIMES

alternative to autologous plates

Stable cortical bone scaffold

maxgraft® cortico is an allogenic bone graft from human donor bone, which is prepared by Cells+Tissuebank Austria in a special purification process (Allotec® process). maxgraft® cortico is a thin, stable cortical plate specially developed for the shell technique. The shell technique creates a biological container which can be filled with particulate bone substitute material, facilitating revascularization and migration of bone-forming cells into the defect zone for rapid bone regeneration1.

Allogenic shell technique

maxgraft® cortico spares the patient the possible source of complications of autologous bone harvesting, the donor site morbidity, as well as the associated pain, which is often greater than with the augmentation itself. The practitioner is also spared the need to divide the bone block and the time-consuming thinning of the bone plates1,2,7.

Looking for prices or further informations?

HIGH PATIENT ACCEPTANCE – SHORTER TREATMENT TIMES

Due to its high biological regenerative capacity and complete remodeling, maxgraft® represents an alternative to the patient’s own bone. The need for a second surgical site is eliminated, surgical time is shortened, and postoperative pain and morbidity for the patient are significantly reduced.

Product Specifications

Art.-No. Particle Size Content
31251 25 x 10 x 1 mm 1 x
31253 25 x 10 x 1 mm 3 x 1

CORTICO TRIMMER

FOR THE ADAPTATION OF CORTICAL PLATES IN THE SHELL TECHNIQUE

Bone augmentation using the shell technique requires precise adaptation of the cortical plates. The cortico timmer provides both a cutting and a drilling aid for allogenic or autologous bone plates.

Distribution

With our international network of distribution partners, we are near you in over 100 countries worldwide. In addition to our 360° productportfolio, we offer service, scientific advice and exchange, training and events directly on site from a single source.

Find a distribution partner near you:

SPECIFIC FACTS

maxgraft® cortico spares the patient the possible source of complications of autologous bone harvesting, the donor site morbidity, as well as the associated pain, which is often greater than with the augmentation itself. The practitioner is also spared the need to divide the bone block and the time-consuming thinning of the bone platelets1,2.
The shell technique creates a biological container between the local bone and the cortical plate. This free space can be filled with the surgeon’s preferred particulate bone substitute material, such as maxgraft® granules or autologous bone chips. The osteoconductive characteristics of maxgraft® allows natural remodeling5,6.
Postoperatively, maxgraft® cortico is primarily integrated. Since the bone plate consists of cortical bone, it is not rapidly resorbed by the body but gradually remodeled. New vital bone forms directly on the side of the allogenic plate facing the local bone. Compared to autologous bone plates, maxgraft® cortico shows comparable, sustained stability1,7.
Rehydration of maxgraft® cortico is recommended. Rehydration of maxgraft® cortico (10 minutes in saline solution) has been shown to increase flexibility and improve the fracture strength of the plate3.

maxgraft® is processed bone graft substitute material from human donors. maxgraft® cortico is completely mineralized cortical bone and originates from the femoral diaphysis of post mortem donors. Procurement is standardized according to a predefined procurement protocol and is performed by certified procurement centers. All tissue donations are made only after the donor has given written consent. In addition, the health status of each potential donor is assessed in advance as part of a risk analysis and the donor is then selected on the basis of strict exclusion criteria.

After a thorough analysis of the donors’ medical history, the high safety of maxgraft® is ensured by a series of rigorous serological tests in combination with the Allotec® purification process of the C+TBA and final radiological sterilization. C+TBA is certified as a tissue procurement facility and tissue bank according to §19 and §22 of the Austrian Tissue Safety Act.

Guide Bone substitute materials

Which product is most suitable for your indication, what are the alternatives and what do you have to pay particular attention to when using it? Our experts have compiled the most important information for you.

botissnews

Stay tuned

Stay informed and never miss any news: Product news, latest publications, exclusive events and exciting webinars. Simply fill out the registration form and you’re in.

Academy

0
Surgeries
0
Webinars
0
Specialists

RELATED PRODUCTS

  • cortico trimmer

    PRECISE ADAPTATION OF MAXGRAFT® CORTICO

    For the adaptation of cortical bone plates with the shell technique.

  • maxgraft® granules

    PROCESSED HUMAN ALLOGRAFT

    Allograft bone substitute from human donor bone, processed by the Cells+Tissuebank Austria with a special cleaning process

  • maxgraft® blocks

    PROCESSED HUMAN ALLOGRAFT

    Allograft bone substitute from human donor bone, processed by the Cells+Tissuebank Austria with a special cleaning process

Contact

Send your questions about our products directly to our specialists:

Product Management

Any comments or questions?

Don’t hesitate to get in touch with us!

botiss biomaterials GmbH

Hauptstrasse 28
15806 Zossen / Germany
Tel.: +49 33769 / 88 41 985
Fax: +49 33769 / 88 41 986
  1. Tunkel et al. Clinical Case Reports 2020, 00:1-13.
  2. Würdinger et al. J Esthet Restor Dent. 2020;1–10.
  3. Pabst et al. J Investig Surg, 2020, 1158-1164.
  4. Wen et al. J. Periodont. 2019, 91(2):215-222.
  5. Trajkovski et al. Materials 2018, 11(2).
  6. Barbeck et al. Materials 2019, 12, 3234.
  7. Kämmerer et al. Int J Implant Dent 2022. 1;8(1):48.